Electromedical Technologies Free Cash Flow (FCF) History (EMED)
Electromedical Technologies reported −$1.6M in free cash flow for fiscal 2023, a free cash flow margin of −116.18%.
View full Electromedical Technologies company overviewElectromedical Technologies free cash flow by year
2023
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2023 | 2023-12-31 | −$1.6M | — | — | −116.18% |
Electromedical Technologies quarterly free cash flow
Q3.23
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2023 | 2023-09-30 | −$277,779 | — | — | −85.84% |
Electromedical Technologies free cash flow growth trends
Electromedical Technologies's latest reported quarter, Q3 2023, generated −$277,779 in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Electromedical Technologies source filings ↗